Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 14.86 M14.56 M16.34 M19.32 M15.98 M15.43 M 67.07 M Research & development —————— — Operating income 714.76 M941.08 M945.28 M949.01 M958.28 M997.85 M 3.85 B Non-Operating Income, Total 3.58 M3.29 M3.8 M6.36 M4.47 M1.88 M 16.51 M Interest expense, net of interest capitalized 209.25 M213.8 M210.33 M210.23 M209.36 M209.93 M 839.86 M Non-Operating Income, excl. Interest Expenses -205.67 M-210.51 M-206.53 M-203.88 M-204.89 M-208.04 M -823.34 M Unusual income/expense —————— — Pretax income 549.81 M883.93 M777.5 M609.73 M889.93 M534.85 M 2.81 B Equity in earnings ———0—— — Taxes -2.46 M5.56 M3.88 M-4.56 M3.97 M-461 K 2.84 M Non-controlling/minority interest 8.66 M13.29 M11.58 M9.52 M13.56 M8.79 M 43.46 M After tax other income/expense —————— — Net income before discontinued operations 543.61 M865.08 M762.04 M604.77 M872.39 M526.52 M 2.77 B Discontinued operations —————— — Net income 543.61 M865.08 M762.04 M604.77 M872.39 M526.52 M 2.77 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 543.61 M865.08 M762.04 M604.77 M872.39 M526.52 M 2.77 B Basic earnings per share (Basic EPS) 0.510.820.710.570.820.48 2.58 Diluted earnings per share (Diluted EPS) 0.510.820.710.570.820.48 2.58 Average basic shares outstanding 1.06 B1.06 B1.07 B1.06 B1.07 B1.09 B — Diluted shares outstanding 1.06 B1.06 B1.07 B1.06 B1.07 B1.09 B — EBITDA 747.62 M973.79 M976.78 M979.9 M989.04 M1.03 B 3.97 B EBIT 734.27 M960.62 M964.83 M967.9 M977.18 M1.02 B 3.93 B Cost of revenue 6.35 M6.62 M6.76 M6.99 M6.47 M7.39 M 27.62 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 13.35 M13.17 M11.94 M12 M11.86 M12.02 M 47.82 M